Home/Filings/4/0001645113-22-000018
4//SEC Filing

DOYLE WILLIAM F 4

Accession 0001645113-22-000018

CIK 0001645113other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 6:21 PM ET

Size

5.4 KB

Accession

0001645113-22-000018

Insider Transaction Report

Form 4
Period: 2022-03-03
DOYLE WILLIAM F
Director10% Owner
Transactions
  • Award

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+14,581$1,175,08314,581 total
    Exercise: $80.59From: 2023-03-01Exp: 2032-02-29Ordinary Shares (14,581 underlying)
Footnotes (1)
  • [F1]Options to buy 14,581 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001194459

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:21 PM ET
Size
5.4 KB